AdvaMed Upset By New Sunshine Requirements In Senate Opioid Bill

By David Roza / September 21, 2018 at 6:07 PM
The Advanced Medical Technology Association (AdvaMed) President and CEO Scott Whitaker is upset the Senate tucked into its recently passed opioid bill a provision expanding the sunshine law to require that drug and medical device makers also publicly disclose payments made to nurse practitioners, physician assistants and midwives – not just doctors and hospitals – for promotional talks, consulting and other interactions. Whitaker applauded the opioid bill overall and expressed his support for the existing sunshine law, which requires drug...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.